Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Raptor Pharmaceutical Corp.

http://www.raptorpharma.com

Latest From Raptor Pharmaceutical Corp.

2021 Deal Action In India: Watch Private Equity And E-Pharmacy

Most roads led to India in 2020 when it came to deals to expand access to COVID-19 therapies, but the challenging year also saw significant private equity interest and there are expectations of more action ahead in the new year.

Deals M & A

Philips, BioIntelliSense Receive $2.8M DoD Award To Validate Wearable For Early COVID-19 Detection

BioIntelliSense is initiating a 2,500-participant virtual study to validate whether its BioSticker can be used for early detection of COVID-19.

Coronavirus COVID-19 Clinical Trials

Keeping Track: J&J Amivantamab, Infectious Disease Agents From Iterum, VBI And Atox Submitted; Another Furoscix CRL

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker

Approvals Complete Response Letters

Now Available: Medtech Insight’s Top 100 Ranking Of Companies By Sales And 2021 Outlook

After a year like no other for the global medtech industry, 2021 will present a different set of market challenges for device and diagnostic companies.

Commercial Outlook 2021
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
      • Site Specific
  • Biotechnology
    • Large Molecule
  • Other Names / Subsidiaries
    • Encode Pharmaceuticals, Inc.
    • TorreyPines Therapeutics, Inc. (Neurogenetics Inc.)
UsernamePublicRestriction

Register